News & Updates

New drug applications approved by US FDA as of 16-31 October 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Extubation with higher levels of nasal continuous positive airway pressure (nCPAP) in preterm infants leads to a lower incidence of extubation failure compared with standard nCPAP levels, without compromising safety, according to a study.

Treatment with nirmatrelvir/ritonavir helps lower the incidence of post-COVID conditions (PCC) in older adults, according to a large study.

Advanced age (≥65 years) and comorbidities increase the risk of respiratory syncytial virus (RSV)-associated hospitalization, according to a presentation at IDWeek 2023.

Nearly 3 percent of the general population demonstrate greater-than-expected values of forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC), which are both indicative of a better lung function, according to a recent study in Austria.